Max Healthcare Institute Limited (NSE:MAXHEALTH)

Max Healthcare Institute Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 3, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	901,285	935,815	1,066,148	797,357	428,177	336,359
Market Cap Growth	-19.14%	-12.22%	33.71%	86.22%	27.30%	69.00%
Enterprise Value	935,537	963,595	1,070,967	786,040	427,502	339,102
Last Close Price	927.15	960.59	1093.74	816.09	438.32	345.46

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 3, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	65.62	64.88	99.10	75.39	38.80	55.59
PS Ratio	9.85	11.18	15.17	14.75	9.38	8.55
PB Ratio	7.81	8.71	11.37	9.48	5.78	5.35
P/TBV Ratio	17.55	19.75	31.87	28.22	18.27	28.70
P/FCF Ratio	151.27	628.95	216.05	237.51	45.14	179.70
P/OCF Ratio	49.23	57.30	74.14	71.09	33.34	45.42

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 3, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	10.23	11.51	15.24	14.54	9.37	8.61
EV/EBITDA Ratio	38.20	44.23	58.49	53.04	34.97	35.83
EV/EBIT Ratio	47.88	53.56	70.11	61.64	41.75	44.74
EV/FCF Ratio	157.02	647.62	217.02	234.14	45.07	181.16

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 3, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.33	0.32	0.32	0.15	0.09	0.14
Debt / EBITDA Ratio	1.55	1.55	1.60	0.86	0.55	0.94
Debt / FCF Ratio	6.37	23.38	6.10	3.87	0.73	4.88
Net Debt / Equity Ratio	0.28	0.26	0.25	0.04	-0.09	0.07
Net Debt / EBITDA Ratio	1.35	1.29	1.28	0.22	-0.56	0.46
Net Debt / FCF Ratio	5.41	18.90	4.76	0.95	-0.72	2.31
Asset Turnover	0.52	0.52	0.52	0.49	0.47	0.44
Inventory Turnover	27.43	28.55	28.50	26.31	25.17	30.36
Quick Ratio	0.73	0.80	0.78	1.19	1.67	1.18
Current Ratio	0.84	0.89	0.88	1.37	1.86	1.32
Return on Equity (ROE)	12.79%	14.33%	12.10%	13.37%	16.12%	10.15%
Return on Assets (ROA)	6.98%	6.93%	7.02%	7.21%	6.64%	5.34%
Return on Invested Capital (ROIC)	10.55%	12.25%	11.43%	12.79%	15.24%	9.68%
Return on Capital Employed (ROCE)	12.00%	12.00%	11.40%	11.90%	11.30%	9.00%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 3, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	1.52%	1.54%	1.01%	1.33%	2.58%	1.80%
FCF Yield	0.66%	0.16%	0.46%	0.42%	2.21%	0.56%
Dividend Yield	0.22%	0.21%	0.14%	0.18%	0.23%	-
Payout Ratio	14.08%	10.10%	13.53%	9.17%	-	-
Buyback Yield / Dilution	0.06%	0.00%	-0.20%	-0.39%	-0.24%	-12.30%
Total Shareholder Return	0.27%	0.21%	-0.07%	-0.20%	-0.01%	-12.30%

Data Source: S&P Global Market Intelligence Last updated: Oct 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error